Angitia Incorporated Limited
Clinical trials sponsored by Angitia Incorporated Limited, explained in plain language.
-
New drug trial aims to strengthen fragile bones
Disease control Recruiting nowThis study is testing an investigational drug called AGA2115 for adults with osteogenesis imperfecta (OI), also known as brittle bone disease. The main goal is to see if the drug can safely increase bone mineral density and reduce the number of fractures. For the first year, part…
Phase: PHASE2 • Sponsor: Angitia Incorporated Limited • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC
-
First human test for new drug compares effects across ethnic groups
Knowledge-focused Recruiting nowThis is an early-stage study to understand how a new drug called AGA2118 moves through the body in healthy people. It will enroll 30 healthy Japanese, Chinese, and Caucasian volunteers to receive a single dose. The main goal is to measure the drug's levels in the blood over time …
Phase: PHASE1 • Sponsor: Angitia Incorporated Limited • Aim: Knowledge-focused
Last updated Apr 01, 2026 23:26 UTC